We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The new antivirals could be rolled out through a clinical study from winter.
The antiviral was found to be safe and effective following a stringent review of the available evidence.…
The public are being urged to sign up to a world-leading study for antivirals if they test positive for COVID-19.
This new combination treatment is for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19
Over 5,000 people have now enrolled in a world-class study for COVID-19 antivirals, meaning thousands of people have accessed the medicines
Thousands of those most at-risk to COVID-19 will soon be able to access the UK’s second ground-breaking antiviral
Prescription charge waiver for COVID-19 antivirals and therapeutic clinical trials to be extended to 31 March 2023.
Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study.
A statement on prescription charges for COVID-19 antiviral medicines.
Thousands of vulnerable people are to receive cutting-edge antiviral and antibody treatments for coronavirus (COVID-19).
This week’s UKHSA surveillance data shows the sharpest weekly increase in flu activity so far this winter, signalling flu season is officially underway.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
The Antivirals Taskforce will identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time.
Findings from the final report of the government-backed REACT-1, one of the largest studies into coronavirus (COVID-19) infections in England, have been published today.
The UK Health Security Agency (UKHSA) announces temporary changes to confirmatory PCR tests.
Letter from Health Minister Maggie Throup confirming UK Health Security Agency’s role and priorities for the financial year 2022 to 2023.
Flu cases have risen to levels not seen before COVID-19 pandemic, with all eligible people now urged to come forward.
The UK Health Security Agency (UKHSA) has today published updated guidance to support the next stage of the COVID-19 pandemic.
Information on who can access free coronavirus (COVID-19) tests from 1 April 2022 and how to get them.
The Secretary of State for Health and Social Care's letter to a group of charities and patients on the decision not to procure Evusheld as a COVID-19 treatment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.